Literature DB >> 10927722

The role of hormone replacement therapy in the prevention of postmenopausal heart disease.

L Mosca1.   

Abstract

Coronary heart disease is the single leading cause of death in women and a significant cause of disability. Menopause adversely affects several risk factors for coronary heart disease, suggesting that hormones influence the risk of coronary heart disease in postmenopausal women. This article reviews the observational and clinical trial data evaluating the relation between cardiovascular disease and hormone replacement therapy. Biological mechanisms of estrogen and the impact of adding progestins are emphasized. Potential risks and benefits of therapy are discussed. The relative effects of other estrogen and lipid-lowering therapies for preventing coronary heart disease in postmenopausal women are highlighted.

Entities:  

Mesh：

Year:  2000        PMID： 10927722     DOI： 10.1001/archinte.160.15.2263

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


  10 in total

1.  Hormone replacement therapy trials: an update.

Authors:  Claire S Duvernoy; Lori Mosca
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

Review 2.  Postmenopausal hormone replacement therapy and atherosclerosis.

Authors:  Jennifer E Ho; Lori Mosca
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 3.  Hormones and heart disease: what we thought, what we have learned, what we still need to know.

Authors:  Marian C Limacher
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

Review 4.  Sex differences in mechanisms of arterial stiffness.

Authors:  Jennifer J DuPont; Rachel M Kenney; Ayan R Patel; Iris Z Jaffe
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

5.  Reciprocal changes in endothelium-derived hyperpolarizing factor- and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomy.

Authors:  Satoshi Nawate; Mitsuhiro Fukao; Ichiro Sakuma; Takamitsu Soma; Kazuhiko Nagai; Osamu Takikawa; Soichi Miwa; Akira Kitabatake
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

Review 6.  Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women.

Authors:  M P Curran; A J Wagstaff
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Association between lumbar bone mineral density and vascular stiffness as assessed by pulse wave velocity in postmenopausal women.

Authors:  Miho Mikumo; Hiroya Okano; Remi Yoshikata; Ken Ishitani; Hiroaki Ohta
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

8.  Debate: The potential role of estrogen in the prevention of heart disease in women after menopause.

Authors:  Rebecca R Johnson; Mary E Sweeney
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000

9.  Differences in the lipid profile and hormone replacement therapy use in Korean postmenopausal women: the Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.

Authors:  Eun Young Ki; Soo Young Hur; Jong Sup Park; Kyung Do Han; Yong Gyu Park
Journal:  Arch Gynecol Obstet       Date:  2015-12-19       Impact factor: 2.344

10.  The Effects of Menopausal Hormone Therapy on Serum Level of C-reactive Protein in Postmenopausal Korean Women.

Authors:  Whan Shin; Sung Eun Kim; Jee-Yeon Lee; Jong-Wook Seo; Hye Sun Hyun; Ji Hyun Suh; DooSeok Choi; Byung-Koo Yoon
Journal:  J Menopausal Med       Date:  2019-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.